Associate Professor | Group Leader+61 7 3845 3020
Associate Professor Michelle Hill obtained her PhD at the University of Queensland on insulin signalling using phosphoproteomics. Her postdoctoral work in Switzerland, Ireland and at the Institute for Molecular Bioscience, University of Queensland focussed on various aspects of signalling using subcellular proteomics. With a passion for translational proteomics research, she established the Cancer Proteomics Group at the University of Queensland Diamantina Institute in 2009. After successfully developing clinical proteomics research, and establishing a proteomics amyloid typing test for the Princess Alexandra Hospital in Brisbane, Associate Professor Hill moved her laboratory to QIMR Berghofer in 2017 to broaden her research program in the Precision and Systems BioMedicine Laboratory to include lipidomics, metabolomics and chronic and mental health conditions.
Associate Professor Hill has been an active member of the Australasian Proteomics Society since 2007, being the Queensland representative on the board for many years. She initiated the Queensland Mass Spectrometry Symposium to encourage local networking. Associate Professor Hill has been an elected member of the international Human Proteome Organisation (HUPO) Council since 2016 and served as the Secretary General for 2019 and 2020.
2020-current: Honorary Associate Professor, University of Queensland Centre for Clinical Research, Faculty of Medicine, University of Queensland
2017-current: Head, Precision & Systems Biomedicine Laboratory, QIMR Berghofer
2009-2017: Head, Cancer Proteomics Group, University of Queensland Diamantina Institute, University of Queensland
2014-2016: Academic Lead, Translational Research Institute Proteomics & Mass Spectrometry Core Facility
2004-2008: Research Officer, Institute for Molecular Bioscience, University of Queensland
2002-2003: Post-doctoral Research Fellow, Trinity College Dublin, Dublin, Ireland
2000-2002: Post-doctoral Research Fellow, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
Associate Professor Hill’s translational research aims to improve modifiable health outcomes by (1) developing better diagnostics, and (2) integrative study of cell membrane disturbance that lead to diseases. Rather than potentially toxic and expensive therapies, her program focuses on early disease detection and non-drug prevention approaches, to empower the public with knowledge and tools to actively maintain wellness. Associate Professor Hill works with a multi-disciplinary team and interdisciplinary collaborators to achieve these goals.
For the past decade, Associate Professor Hill’s research has addressed unmet clinical needs in cancer including:
Her research combines cell biology and biochemistry knowledge with cutting edge multi-omics technologies in the “wet-lab” with sophisticated computational algorithms (“dry-lab”).
2019-current: International Society for Extracellular Vesicles
2012-current: American Society for Biochemistry and Molecular Biology
2010-current: Australian Society for Medical Research
2007-current: Human Proteome Organization
2007-current: Australasian Proteomics Society
2006-current: Australian Society for Biochemistry and Molecular Biology
2000: PhD, University of Queensland
1995: B.Sc. Hons (First class), University of Queensland
1994: Parallel B.Sc., B.A., University of Queensland